Bio-Rad Laboratories, Inc. (BIO) Tax Rate: 23.67%
Is Bio-Rad Laboratories, Inc.’s tax rate high or low?
Bio-Rad Laboratories, Inc.'s tax rate of 23.67% is in line with its 5-year average of 22.87%, around the middle of its 5-year range (21.27%–25.03%).
The tax rate for Bio-Rad Laboratories, Inc. (BIO) is 23.67%. It is above its 12-month average by 5.34% (22.47%).
BIO Tax Rate Chart
BIO Average Tax Rate Chart
BIO Current vs Average Tax Rate Chart
BIO Tax Rate Metrics
TAX RATE
23.67%
TAX RATE AVG TTM
22.47%
TAX RATE AVG 3Y
23.21%
TAX RATE AVG 5Y
22.87%
TAX RATE AVG 10Y
20.52%
TAX RATE AVG 15Y
22.22%
TAX RATE AVG 20Y
22.51%
CURRENT VS TTM AVG
+5.34%
CURRENT VS 3Y AVG
+1.96%
CURRENT VS 5Y AVG
+3.49%
CURRENT VS 10Y AVG
+15.33%
CURRENT VS 15Y AVG
+6.53%
CURRENT VS 20Y AVG
+5.17%
Bio-Rad Laboratories, Inc. Tax Rate Formula & Definition
Tax rate measures income tax expense as a percentage of income before tax. It helps compare tax efficiency and identify unusual tax effects.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Bio-Rad Laboratories, Inc. Tax Rate FAQ
- What is the tax rate for Bio-Rad Laboratories, Inc. (BIO)?
- The tax rate for BIO stock is 23.67%.
- Is Bio-Rad Laboratories, Inc.'s tax rate high or low?
- Bio-Rad Laboratories, Inc.'s tax rate of 23.67% is in line with its 5-year average of 22.87%, around the middle of its 5-year range (21.27%–25.03%).
- What is the TTM average tax rate for Bio-Rad Laboratories, Inc. (BIO)?
- The TTM average tax rate for BIO stock is 22.47%.
- What is the 3Y average tax rate for Bio-Rad Laboratories, Inc. (BIO)?
- The 3Y average tax rate for BIO stock is 23.21%.
- What is the 5Y average tax rate for Bio-Rad Laboratories, Inc. (BIO)?
- The 5Y average tax rate for BIO stock is 22.87%.
- What is the 10Y average tax rate for Bio-Rad Laboratories, Inc. (BIO)?
- The 10Y average tax rate for BIO stock is 20.52%.
- What is the 15Y average tax rate for Bio-Rad Laboratories, Inc. (BIO)?
- The 15Y average tax rate for BIO stock is 22.22%.
- What is the 20Y average tax rate for Bio-Rad Laboratories, Inc. (BIO)?
- The 20Y average tax rate for BIO stock is 22.51%.
Bio-Rad Laboratories, Inc. Tax Rate History
| DATE | TAX RATE |
|---|---|
| 2025-12-31 | 23.67% |
| 2024-12-31 | 21.27% |
| 2023-12-31 | 25.03% |
| 2022-12-31 | 22.89% |
| 2021-12-31 | 21.93% |
| 2020-12-31 | 22.44% |
| 2019-12-31 | 22.22% |
| 2018-12-31 | 28.85% |
| 2017-12-31 | -17.32% |
| 2016-12-31 | 32.33% |
| 2015-12-31 | 22.46% |
| 2014-12-31 | 32.47% |
| 2013-12-31 | 30.76% |
| 2012-12-31 | 26.89% |
| 2011-12-31 | 24.49% |
| 2010-12-31 | 15.14% |
| 2009-12-31 | 19.73% |
| 2008-12-31 | 31.21% |
| 2007-12-31 | 21.97% |
| 2006-12-31 | 27.29% |
| 2005-12-31 | 16.91% |
| 2004-12-31 | 31.89% |
| 2003-12-31 | 33.00% |
| 2002-12-31 | 35.00% |
| 2001-12-31 | 32.00% |
| 2000-12-31 | 30.00% |
| 1999-12-31 | 28.66% |
| 1998-12-31 | 28.95% |
| 1997-12-31 | 28.07% |
| 1996-12-31 | 24.93% |
Related Metrics
About Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc., established in 1952 and headquartered in Hercules, California, operates as a global provider of life science research and clinical diagnostic products. Its operations span across the United States, Canada, Europe, Asia, and Latin America. The company is organized into two primary divisions: Life Science and Clinical Diagnostics. The Life Science division is responsible for developing, manufacturing, and commercializing a diverse array of reagents, equipment, and laboratory instruments. These products are crucial for various research methodologies, biopharmaceutical manufacturing processes, and food quality testing. This segment focuses on specialized areas within the life sciences, including proteomics, genomics, biopharmaceutical production, cellular biology, and food safety. Its clientele encompasses academic institutions (such as universities and medical schools), industrial research organizations, government agencies, pharmaceutical companies, biotechnology firms, food producers, and food testing laboratories. In contrast, the Clinical Diagnostics division designs, produces, sells, and supports a comprehensive suite of test systems, informatics solutions, diagnostic kits, and specialized quality control products for clinical laboratories. This segment provides reagents, instruments, and software specifically tailored for particular niches within the in vitro diagnostics market. Its customer base includes reference laboratories, hospital laboratories, state newborn screening facilities, physicians' office laboratories, and transfusion laboratories. Beyond these core segments, Bio-Rad also offers systems and products designed to separate complex chemical and biological materials, as well as to identify, analyze, and purify their individual components. The company distributes its extensive product portfolio through a combination of its direct sales force and a network of third-party distributors, agents, brokers, and resellers.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Norman D. Schwartz